Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

MLA

Yoshizato, Tetsuichi, et al. “Genetic Abnormalities in Myelodysplasia and Secondary Acute Myeloid Leukemia: Impact on Outcome of Stem Cell Transplantation.” Blood, vol. 129, no. 17, Apr. 2017, pp. 2347–58. EBSCOhost, https://doi.org/10.1182/blood-2016-12-754796.

APA

Yoshizato, T., Nannya, Y., Atsuta, Y., Shiozawa, Y., Iijima-Yamashita, Y., Yoshida, K., Shiraishi, Y., Suzuki, H., Nagata, Y., Sato, Y., Kakiuchi, N., Matsuo, K., Onizuka, M., Kataoka, K., Chiba, K., Tanaka, H., Ueno, H., Nakagawa, M. M., Przychodzen, B., … Ogawa, S. (2017). Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Blood, 129(17), 2347–2358. https://doi.org/10.1182/blood-2016-12-754796

Chicago

Yoshizato, Tetsuichi, Yasuhito Nannya, Yoshiko Atsuta, Yusuke Shiozawa, Yuka Iijima-Yamashita, Kenichi Yoshida, Yuichi Shiraishi, et al. 2017. “Genetic Abnormalities in Myelodysplasia and Secondary Acute Myeloid Leukemia: Impact on Outcome of Stem Cell Transplantation.” Blood 129 (17): 2347–58. doi:10.1182/blood-2016-12-754796.